Identification of potential extracellular vesicle protein markers altered in osteosarcoma from public databases
- PMID: 36571514
- DOI: 10.1002/prca.202200084
Identification of potential extracellular vesicle protein markers altered in osteosarcoma from public databases
Abstract
Purpose: Extracellular vesicles (EVs) have become promising biomarkers for cancer management. Particularly, the molecular cargo such as proteins carried by EVs are similar to their cells of origin, providing important information that can be used for cancer diagnostics, prognosis, and treatment monitoring. However, to date, molecular analysis on EVs is still challenging, limited by the availability of efficient analytical technologies, largely due to the small size of EVs. In this work, we developed a computational workflow for in silico identification of potential EV protein markers from genomic and proteomic databases, and applied it for the discovery of osteosarcoma (OS) EV protein markers.
Experimental design: Both mRNA and protein data were computed and compared from publicly accessible databases, and top markers with high differential expression levels were selected.
Results: Thirty nine markers were identified overexpressed and seven found to be downregulated. These identified markers have been found to be associated with OS on different aspects in literature, demonstrating the usability of this workflow.
Conclusions and clinical relevance: This work provides a list of potential EV protein markers that are either overexpressed or downregulated in OS for further experimental validation for improved clinical management of OS.
Keywords: biomarkers; extracellular vesicles; osteosarcoma; proteins.
© 2023 Wiley-VCH GmbH.
Similar articles
-
Extracellular Vesicle RNA Sequencing Reveals Dramatic Transcriptomic Alterations Between Metastatic and Primary Osteosarcoma in a Liquid Biopsy Approach.Ann Surg Oncol. 2018 Sep;25(9):2642-2651. doi: 10.1245/s10434-018-6642-z. Epub 2018 Jul 6. Ann Surg Oncol. 2018. PMID: 29981024
-
Extracellular vesicle-associated repetitive element DNAs as candidate osteosarcoma biomarkers.Sci Rep. 2021 Jan 8;11(1):94. doi: 10.1038/s41598-020-77398-z. Sci Rep. 2021. PMID: 33420117 Free PMC article.
-
Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles.Epigenetics. 2019 Apr;14(4):352-364. doi: 10.1080/15592294.2019.1585177. Epub 2019 Mar 24. Epigenetics. 2019. PMID: 30907225 Free PMC article.
-
Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma.Front Immunol. 2022 Sep 23;13:1002742. doi: 10.3389/fimmu.2022.1002742. eCollection 2022. Front Immunol. 2022. PMID: 36211364 Free PMC article. Review.
-
Towards the realization of clinical extracellular vesicle diagnostics: challenges and opportunities.Expert Rev Mol Diagn. 2015;15(12):1555-66. doi: 10.1586/14737159.2015.1104249. Epub 2015 Oct 26. Expert Rev Mol Diagn. 2015. PMID: 26502802 Review.
Cited by
-
Targeting metastasis in paediatric bone sarcomas.Mol Cancer. 2025 May 29;24(1):153. doi: 10.1186/s12943-025-02365-z. Mol Cancer. 2025. PMID: 40442778 Free PMC article. Review.
References
REFERENCES
-
- Cloet, T., Momenbeitollahi, N., & Li, H. (2021). Recent advances on protein-based quantification of extracellular vesicles. Analytical Biochemistry, 622, 114168. https://doi.org/10.1016/j.ab.2021.114168
-
- Pang, B., Zhu, Y., Ni, J., Thompson, J., Malouf, D., Bucci, J., Graham, P., & Li, Y. (2020). Extracellular vesicles: The next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis. Theranostics, 10(5), 2309-2326. https://doi.org/10.7150/thno.39486
-
- Momenbeitollahi, N., Aggarwal, R., Strohle, G., Bouriayee, A., & Li, H. (2022). Extracellular Vesicle (EV) dot blotting for multiplexed ev protein detection in complex biofluids. Analytical Chemistry, 7368-7374. https://doi.org/10.1021/acs.analchem.2c00846
-
- Misaghi, A., Goldin, A., Awad, M., & Kulidjian, A. A. (2018). Osteosarcoma: A comprehensive review. SICOT J, 4, 12-12. https://doi.org/10.1051/sicotj/2017028
-
- Suehara, Y., Kubota, D., Kikuta, K., Kaneko, K., Kawai, A., & Kondo, T. (2012). Discovery of biomarkers for osteosarcoma by proteomics approaches. Sarcoma, 2012, 1-15. https://doi.org/10.1155/2012/425636
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical